Platelet membrane activation markers are predictive for increased risk of acute ischemic events after PTCA.
- 1 July 1993
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 88 (1) , 37-42
- https://doi.org/10.1161/01.cir.88.1.37
Abstract
BACKGROUND We wished to investigate whether platelet activation is related to the clinical outcome during the 24 hours immediately after elective percutaneous transluminal coronary angioplasty (PTCA). METHODS AND RESULTS In 102 patients with high-grade coronary stenosis admitted for elective PTCA, preprocedural platelet activation was characterized by flow cytometric measurement of the proteins CD62, CD63, and thrombospondin expressed on the platelet surface membrane. The prevalence of acute ischemic events during the 24 hours immediately after the procedure was then related to the pre-PTCA platelet activation status. Fifty-six patients were classified as "nonactivated," whereas 46 patients showed an increased percentage of activated platelets. Two patients developed acute occlusion (1.96%) and four patients high-grade restenosis (3.92%), as confirmed by second-look coronary angiography. All events occurred in patients classified as "activated" (six of 46, or 13%). None of these patients received beta-blocker medication, which was associated with lower expression of platelet membrane activation markers. In the nonactivated patient group, no clinical events were found (0 of 56, or 0%). This difference in prevalence is significant (p = 0.007). CONCLUSIONS We conclude that analysis of platelet membrane activation markers may help to predict an increased risk of acute ischemic events after angioplasty.Keywords
This publication has 24 references indexed in Scilit:
- Platelet Hyperreactivity and Prognosis in Survivors of Myocardial InfarctionNew England Journal of Medicine, 1990
- Re-Stenosis after Successful Coronary AngioplastyNew England Journal of Medicine, 1988
- Aspirin and Dipyridamole in the Prevention of Re-Stenosis after Percutaneous Transluminal Coronary AngioplastyNew England Journal of Medicine, 1988
- Role of percutaneous transluminal coronary angioplasty in multivessel diseaseThe American Journal of Cardiology, 1988
- Use of percutaneous transluminal coronary angioplasty: Results of a current surveyThe American Journal of Cardiology, 1988
- Statistical Problems in the Reporting of Clinical TrialsNew England Journal of Medicine, 1987
- Restenosis after arterial angioplasty: A hemorrheologic response to injuryThe American Journal of Cardiology, 1987
- Frequency, management and follow-up of patients with acute coronary occlusions after percutaneous transluminal coronary angioplastyThe American Journal of Cardiology, 1987
- Platelet Activation in Unstable Coronary DiseaseNew England Journal of Medicine, 1986
- Platelets and Ischemic Heart DiseaseNew England Journal of Medicine, 1980